Revance Therapeutics Inc. buy BiotechBee
Start price
03.01.23
/
70%
€17.50
Target price
31.12.25
€30.00
Performance (%)
76.00%
End price
05.05.23
€30.80
Summary
This prediction ended on 05.05.23 with a price of €30.80. With a performance of 76.00% the BUY prediction by BiotechBee was a big success. BiotechBee has 70% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Revance Therapeutics Inc. | - | - | - | - |
| iShares Core DAX® | -1,10 % | -6,08 % | 3,20 % | 53,31 % |
| iShares Nasdaq 100 | 0,33 % | 2,33 % | 20,24 % | 93,48 % |
| iShares Nikkei 225® | -1,08 % | -7,99 % | 27,55 % | 52,32 % |
| iShares S&P 500 | -0,06 % | 0,88 % | 14,89 % | 66,74 % |
According to BiotechBee what are the pros and cons of Revance Therapeutics Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year